
Rayyan
7.5#3 in ai literature review softwareFrom $4.99 a monthFree planAndroidiOSWebAPI
Visit
| Fact | Rayyan | RevMan |
|---|---|---|
| API | API access includes programmatic access to reviews, references, decisions, and metadata, an official Python SDK, workflow automation, and external system integrations. | Cochrane documents Review Document, ReviewDB and Group APIs, including a REST ReviewDB endpoint at api.cochrane.org. |
| Headquarters | Cambridge, Massachusetts, USA | London, United Kingdom |
| Integrations | Rayyan accepts exported reference files from external databases and reference managers; it says there is no direct database connection. | RevMan can import study data and references from Covidence, and RIS reference imports can use data from Crossref, PubMed, or CRS. |
| Purpose | Rayyan is a systematic review platform for teams conducting transparent, auditable, and reproducible evidence reviews. | RevMan is Cochrane’s software for producing transparent systematic reviews, guiding authors from structured data entry and analysis through result visualization. |
| Security | Rayyan's enterprise page states HIPAA and GDPR compliance, SOC 2 controls, encryption in transit and at rest, and support for SAML 2.0, OAuth, and MFA. | Cochrane states that RevMan Web is GDPR compliant, hosted on AWS with SOC 2 Type 2 controls, uses 256-bit SSL, encryption at rest, OIDC single sign-on, permission separation, monitoring and daily backups. |
It suits research teams screening and analysing evidence across a systematic review workflow. The intended organisation users include pharma, medical-device, CRO, university, healthcare, government, and health technology assessment teams.
RevMan suits authors preparing systematic reviews across its listed review types, including people working collaboratively on analysis and writing. The free practice option may suit someone who can work within its deletion, export, and single-user limits.